Take Action
Call Your Senators
As healthcare costs continue to skyrocket, our elected officials must enact policies that ensure affordable and accessible insulin, medications, and devices, rather than protecting the profits of the pharmaceutical industry.
Calling your Senators is the best way to let them know that you are holding them accountable.
Each campaign below has a summary of the issue, a sample script, and your Senators’ phone numbers to help you.
Campaigns
Hold Dexcom Accountable for Failed Adhesive
Dexcom's new CGM replacement policy puts profits over patients' lives. While 37.3 million Americans with diabetes rely on continuous glucose monitors to prevent life-threatening complications, Dexcom now limits replacements for failed sensors to just three per year. When their adhesive fails - during everyday activities like exercising or showering - patients must choose between paying $400 monthly for replacements or risking their health by going without this essential monitoring device. Despite their $4 billion annual revenue, Dexcom is forcing patients to bear the cost of their product failures, highlighting the urgent need for FDA intervention.